Delivery Order SPE2DE24D0021-SPE2D625F4HCJ
- Not listed
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $3,789.98 for RNA isolation and purification products under a fixed price contract with economic price adjustment provisions. The award was issued on August 6, 2025, with an ultimate completion date of August 13, 2025, and will be performed in Pittsburgh, PA. The contract represents an open competition award with no set-aside designation to the Medical Supply Chain, a defense-focused federal agency. This delivery...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $4,096.99 by the Medical Supply Chain, a defense-affiliated federal agency, on August 1, 2025, for RNA isolation and purification products. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of August 13, 2025. Performance will be completed in Pittsburgh, Pennsylvania. This award represents a child contract under a larger vehicle and...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,445.78 for RNA isolation and purification products by the Defense Medical Supply Chain on August 7, 2025. The contract is structured as a fixed-price agreement with economic price adjustment provisions and is classified as a child contract under a larger vehicle. Performance will be completed in Pittsburgh, Pennsylvania, with an ultimate completion date of August 21, 2025. No set-aside designation was applied to this...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $4,201.61 to Fisher Scientific Company L.L.C. for RNA isolation and purification products on September 11, 2025, with an ultimate completion date of September 18, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation, indicating open competition procurement. The work will be performed in Pittsburgh, Pennsylvania, and represents a child contract under a larger...
- This federal contract award, issued by the Department of Defense's Medical Supply Chain agency, is for the delivery of RNA isolation and purification products to support federal research, testing, and healthcare initiatives. The $1,922.00 fixed-price with economic price adjustment delivery order was awarded to Fisher Scientific Company L.L.C. on August 14, 2024, with a completion date of August 21, 2024. The contract does not utilize a set-aside designation. Fisher Scientific is a major supplier...
- This federal contract award was issued by the Medical Supply Chain division of a U.S. government defense agency to Fisher Scientific Company L.L.C., a major supplier of scientific products, equipment, and services to federal agencies. The $3,789.98 fixed-price delivery order is for RNA isolation and purification products, with a completion date of June 18, 2025. The contract does not utilize a set-aside designation, indicating Fisher Scientific's ability to compete effectively in open federal...
- The U.S. Defense agency Medical Supply Chain awarded a $2,572.00 fixed-price delivery order contract to Fisher Scientific Company L.L.C. for RNA isolation and purification products. The contract, which does not have a set-aside designation, has a completion date of September 20, 2024. Fisher Scientific is a major supplier of scientific products and services to federal agencies, providing a wide range of laboratory equipment, consumables, and diagnostic testing kits. This delivery order...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,080.20 for a nucleic acid purification system accessory by the Defense Department's Medical Supply Chain division. The contract, awarded on August 7, 2025, with an ultimate completion date of August 14, 2025, is structured as a fixed-price delivery order with economic price adjustment provisions. The place of performance is Pittsburgh, Pennsylvania. This delivery order represents a child contract, indicating it falls...
- The U.S. Department of Defense's Medical Supply Chain awarded a $3,636.00 fixed-price delivery order contract to Fisher Scientific Company L.L.C. for the supply of RNA isolation and purification products. The contract has an ultimate completion date of August 22, 2024. Fisher Scientific, a major supplier of scientific products, equipment, and services to federal agencies, is providing these items without any set-aside designation. This contract award is likely part of a larger Multiple Award...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Fisher Scientific Company L.L.C., doing business as Fisher Scientific, a for-profit limited liability company. The contract is for the procurement of RNA isolation and purification products with a ceiling value of $3,626.00. The contract is a Delivery Order with a fixed price and economic price adjustment pricing type, and has an ultimate completion date of April 29, 2025. The contract does not have a set-aside...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F4HCJDelivery Order
Fisher Scientific Company L.L.C. was awarded a delivery order valued at $5,149.92 for RNA isolation and purification products on September 26, 2025, with an ultimate completion date of October 3, 2025. This fixed-price contract with economic price adjustment was issued by the Defense-related Medical Supply Chain agency and does not utilize a set-aside designation, indicating open competition. The place of performance is Pittsburgh, Pennsylvania. As a child contract under a larger vehicle, this delivery order leverages Fisher Scientific's established position as a major federal supplier of laboratory and scientific products, building on the company's extensive history of providing specialized equipment and supplies to government agencies since its registration in SAM.gov in 2001. Fisher Scientific's award reflects its demonstrated capability to supply critical laboratory reagents and materials to federal agencies. The company maintains significant contract relationships across multiple departments, including the National Institutes of Health, Department of Veterans Affairs, and various defense-related agencies, and holds a notable Blanket Purchase Agreement with the Department of Veterans Affairs' Veterans Integrated Service Network 1 valued at $1.65 million for toxicology and drugs of abuse testing supplies. This RNA isolation and purification order supports the Defense agency's medical supply chain operations and represents a continuation of Fisher Scientific's role as a reliable vendor for specialized laboratory materials required by federal healthcare and research initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 9/26/25 |